SyVento is a biotechnology company offering comprehensive services in the development of lipid-based nanocarriers and LNP technology. The company specializes in the development of lipid-based formulations for pharmaceutical products, including RNA-based drug products. The expertise includes the development of liposomal formulations, RNA synthesis, and finally cGMP production in our state-of-the-art facility, along with support services at all levels of product development.
-
Portfolio
SciTech
Sector
Biotechnology
Ownership
100%
Since
2020
Through
Startup
Website
www.syvento.com